ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "In conversation with... Paolo Strati"
Episode Synopsis
Paolo Strati joins us to discuss the results of a multicentre, open-label, phase 1 clinical trial of off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy for patients with relapsed or refractory B-cell lymphoma.
More episodes of the podcast Listen to The Lancet Haematology
In conversation with... Arnon Kater
08/12/2025
ASH 2025 Preview - Expert Roundtable
02/12/2025
In conversation with... Ruben Mesa
03/11/2025
In conversation with... Michael Northend
28/04/2025
In conversation with... Michael Northend
28/04/2025
In God we trust